Core Viewpoint - *ST Huicheng has selected Zhi'en Biotechnology as the restructuring investor during its pre-restructuring phase, but no formal agreement has been signed yet, leaving future collaboration uncertain [1][2] Group 1: Company Developments - *ST Huicheng has experienced a stock price increase of 15.83% over three consecutive trading days, followed by a decline of 4.95% on the latest trading day, closing at 4.80 yuan [1] - The company has initiated the recruitment of restructuring investors since August 9, with three potential investors meeting the requirements and submitting their materials [1] - Zhi'en Biotechnology was selected as the restructuring investor based on a comprehensive evaluation of submitted restructuring investment proposals [1][2] Group 2: Zhi'en Biotechnology Overview - Zhi'en Biotechnology, established in April 2001, focuses on building a drug lifecycle management service system and holds various qualifications, including being a national high-tech enterprise [2] - The company has over 50 products, including key medications such as orlistat capsules for weight loss and donepezil hydrochloride tablets for Alzheimer's disease [2][3] - Zhi'en Biotechnology is the largest global supplier of orlistat, having achieved full synthetic industrial production of the active pharmaceutical ingredient [3] Group 3: Previous Collaborations - Prior to the restructuring investment selection, *ST Huicheng and Zhi'en Biotechnology had collaborated, with *ST Huicheng acquiring a 51% stake in Chongqing Rui'en Pharmaceutical for 47 million yuan [4] - The biopharmaceutical business, including Rui'en Pharmaceutical, has become a significant revenue contributor for *ST Huicheng, accounting for 57.41% of its revenue in the first half of the year [4] - Rui'en Pharmaceutical reported a revenue of 122 million yuan and a net profit of 23.44 million yuan in the first half of the year [4]

证券代码：002168 证券简称：*ST惠程 公告编号：2025－074 关于公司股票交易异常波动的公告 本公司及董事会全体成员保证公告内容的真实、准确、完整，不存在虚假记 载、误导性陈述或重大遗漏。 一、公司股票交易异常波动的情况介绍 重庆惠程信息科技股份有限公司（以下简称"公司"，证券简称：*ST惠程， 证券代码：002168）的股票交易价格在2025年8月28日、8月29日、9月1日连续三 个交易日收盘价格涨幅偏离值累计超过12%，根据《深圳证券交易所交易规则》 的有关规定，属于股票交易异常波动的情形。 二、公司关注、核实的相关情况说明 针对公司股票异常波动的情形，公司董事会通过电话沟通、致函询问等方式 向公司控股股东、实际控制人就相关事项进行了核实，有关情况说明如下： 1.经核查，公司前期披露的信息不存在需要更正、补充之处。 2.公司未发现近期公共传媒报道了可能或已经对公司股票交易价格产生较 大影响的未公开重大信息。 3.2025年8月4日，公司在巨潮资讯网（www.cninfo.com.cn）披露了《关于公 司被债权人申请预重整的提示性公告》（公告编号：2025-060），公司债权人重庆 绿发资产经 ...

证券代码：002168 证券简称：*ST惠程 公告编号：2025－073 重庆惠程信息科技股份有限公司 关于公开招募重整投资人的进展公告 本公司及董事会全体成员保证公告内容的真实、准确、完整，不存在虚假记 载、误导性陈述或重大遗漏。 一、基本情况概述 2025年8月4日，重庆惠程信息科技股份有限公司（以下简称"公司"）在巨潮 资讯网（www.cninfo.com.cn）披露了《关于公司被债权人申请预重整的提示性公 告》（公告编号：2025-060），公司债权人重庆绿发资产经营管理有限公司以公司 不能清偿到期债务且明显缺乏清偿能力，但具备重整价值为由，向重庆市第五中 级人民法院（以下简称"重庆五中院"）提交对公司进行预重整的申请，不包含公 司子公司。 根据《重庆市第五中级人民法院预重整与破产重整衔接工作规范（试行）》， 重庆五中院已经完成对公司预重整的备案登记。经公司主要债权人同意，公司已 聘任北京市天元律师事务所和天健会计师事务所（特殊普通合伙）重庆分所联合 担任公司预重整辅助机构（以下简称"辅助机构"）。 2025年8月9日，公司在巨潮资讯网披露了《关于公开招募重整投资人的公告》 （公告编号：2025-06 ...

New Stock Issuance - New stock issuance for AiFenda (301575) is priced at 27.69 RMB, effective from September 1, 2025[1] - Fushun Special Steel (600399) is undergoing a tender offer from August 12 to September 10, 2025[1] - KaiPu Cloud (688228) has a recent announcement regarding its stock[1] Market Alerts - Significant abnormal fluctuations reported for Siquan New Materials (301489) on August 22, 2025[1] - New announcements for various stocks including Xinhua Jin (600735) and Jishi Media (601929) on August 30, 2025[1] - Multiple stocks including ST Guohua (000004) and ST Huayang (603825) have recent updates as of August 29, 2025[1] Trading Insights - The report includes links to detailed announcements for stocks experiencing significant market activity, such as ST Zhongji (000972) and ST Yilanzhong (300096)[1] - The document highlights the importance of monitoring stock performance and related announcements for investment decisions[1]

Core Viewpoint - *ST Huicheng has experienced a significant stock price increase, achieving a limit-up and marking three consecutive trading days of gains, with a total increase of 15.83% over the past three days [1] Company Summary - The stock of *ST Huicheng has reached a limit-up, indicating strong market interest and investor confidence [1] - The cumulative increase of 15.83% over three days suggests a positive trend in the company's stock performance [1]

Core Viewpoint - *ST Huicheng (002168) reported a significant increase in revenue and a reduction in net loss for the first half of 2025, indicating potential recovery despite ongoing challenges [1]. Financial Performance Summary - Total revenue for the first half of 2025 reached 180 million yuan, a year-on-year increase of 61.54% compared to 111 million yuan in 2024 [1]. - The net profit attributable to shareholders was -31.67 million yuan, improving by 54.36% from -69.39 million yuan in the previous year [1]. - The gross profit margin improved to 51.22%, a substantial increase of 267.85% from 13.93% in 2024 [1]. - The net profit margin also improved to -14.06%, up 77.82% from -63.38% in the previous year [1]. - Operating cash flow per share increased to 0.07 yuan, a significant rise of 201.36% from -0.06 yuan [1]. Changes in Financial Items - Cash and cash equivalents increased by 328.26% to 65.89 million yuan due to increased sales collections [3]. - Accounts receivable rose by 71.18% to 246 million yuan, attributed to the consolidation of Reen Pharmaceutical [3]. - Long-term borrowings increased by 56.9% due to new long-term loans taken during the reporting period [4]. - Contract liabilities surged by 405.52% as a result of receiving project prepayments [4]. Cost and Expense Analysis - Sales expenses increased by 436.73% due to the addition of the pharmaceutical segment [4]. - Management expenses decreased by 48.2% as the company implemented cost-cutting measures [4]. - Research and development expenses rose by 108.33%, reflecting investment in the new pharmaceutical business [4]. Cash Flow and Debt Situation - The net cash flow from operating activities increased by 201.36%, driven by improved sales collections [4]. - The net increase in cash and cash equivalents was up by 151.56%, also due to increased sales collections [4]. - The company’s debt situation shows a significant reliance on interest-bearing liabilities, with a debt-to-asset ratio of 40.18% [5].

本次公司申请撤销其他风险警示事项不涉及股票停牌，公司股票正常交易。 格隆汇8月29日丨*ST惠程(002168.SZ)公布，2025年8月28日，公司召开第八届董事会第十三次会议，审 议通过《关于申请撤销公司股票其他风险警示的议案》，同意公司向深圳证券交易所申请撤销公司股票 其他风险警示。 鉴于公司2024年度经审计的期末归母净资产为负数、扣除非经常性损益后的净利润为负数且扣除后的营 业收入低于3亿元，公司股票自2025年4月30日起被实施退市风险警示。如深圳证券交易所核准公司本次 撤销公司股票其他风险警示的申请，公司股票仍继续被实施退市风险警示，公司股票简称仍为"*ST惠 程"，公司股票交易的日涨跌幅限制仍为5%。 ...

Core Viewpoint - *ST Huicheng (002168.SZ) reported a significant increase in revenue for the first half of 2025, but still faced substantial net losses [1] Financial Performance - The company achieved an operating revenue of 180 million yuan, representing a year-on-year growth of 61.54% [1] - The net profit attributable to shareholders of the listed company was -31.67 million yuan [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was -27.44 million yuan [1] - The basic earnings per share were -0.0404 yuan [1]

Core Insights - *ST Huicheng reported a decrease in the number of shareholders to 32,887 as of June 30, 2025, down by 4,564 or 12.19% from March 31, 2025 [1][2] - The average number of shares held per shareholder increased from 20,900 to 23,800, with an average market value of 79,200 yuan [1][2] - The stock price of *ST Huicheng increased by 48.21% during the period from March 31, 2025, to June 30, 2025, despite the reduction in shareholder numbers [1][2] Company Performance - As of June 30, 2025, *ST Huicheng's shareholder count was below the industry average of 37,700 [1] - The average market value of shares held by shareholders in the electric grid equipment industry was 244,400 yuan, significantly higher than *ST Huicheng's average [1] - From March 31, 2025, to June 30, 2025, the net outflow of main funds was 71.77 million yuan, while retail investors contributed a net inflow of 54.69 million yuan [2] Historical Comparison - The number of shareholders decreased from 40,161 on December 31, 2024, to 32,887 on June 30, 2025, reflecting a significant decline of 24.72% over the period [2] - The stock experienced a price drop of 19.13% from December 31, 2024, to March 31, 2025, before rebounding with a 48.21% increase in the subsequent quarter [2] - The average market value of shares held by shareholders has shown a steady increase from 41,000 yuan in September 2024 to 79,200 yuan in June 2025 [2]

Core Viewpoint - The company reported a significant increase in revenue for the first half of 2025, but still faced a net loss, indicating ongoing financial challenges despite improved operational performance [1][2]. Financial Performance - The company's operating revenue for the reporting period reached ¥179,792,680.55, representing a 61.54% increase compared to ¥111,298,587.00 in the same period last year [1]. - The net profit attributable to shareholders was a loss of ¥31,666,573.45, which is an improvement of 54.36% from a loss of ¥69,385,458.73 in the previous year [1]. - The net profit after deducting non-recurring gains and losses was a loss of ¥27,444,740.03, showing a 59.37% improvement from a loss of ¥67,542,511.49 [1]. - The net cash flow from operating activities was ¥51,188,378.54, a significant increase of 201.36% compared to a negative cash flow of ¥50,502,770.43 in the previous year [1]. Balance Sheet - Total assets at the end of the reporting period were ¥952,069,286.07, reflecting a 20.33% increase from ¥791,218,924.57 at the end of the previous year [2]. - The net assets attributable to shareholders were negative at ¥-95,785,444.50, a decline of 74.72% from ¥-54,823,505.99 at the end of the previous year [2]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 32,887 [2]. - The largest shareholder, Chongqing Green Development Urban Construction Co., Ltd., holds 12.15% of the shares, amounting to 95,303,911 shares [2]. - Other significant shareholders include Zhongchi Huicheng Enterprise Management Co., Ltd. with 5.90% and Hu Zuping with 3.95% [2]. Important Matters - The company did not distribute cash dividends, issue bonus shares, or increase capital from reserves during the reporting period [1][4]. - There were no changes in the controlling shareholder or actual controller during the reporting period [4].